Hangzhou AGS MedTech Co. Ltd. A Total Liabilities

Latest as of March 2026: CN¥127.24 Million CNY ≈ $18.62 Million USD

Hangzhou AGS MedTech Co. Ltd. A total liabilities. Based on the latest financial reports, Hangzhou AGS MedTech Co. Ltd. A (688581) has total liabilities worth CN¥127.24 Million CNY (≈ $18.62 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 688581 asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hangzhou AGS MedTech Co. Ltd. A (2021–2025)

Total liabilities of Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025. This chart illustrates how Hangzhou AGS MedTech Co. Ltd. A's total liabilities have evolved over time, based on quarterly financial data.

Hangzhou AGS MedTech Co. Ltd. A Competitors by Total Liabilities

The table below lists competitors of Hangzhou AGS MedTech Co. Ltd. A ranked by their total liabilities.

Company Country Total Liabilities
Hengyuan Refining Company Bhd
KLSE:4324
Malaysia RM3.59 Billion
Hangzhou Jizhi Mechatronic Co Ltd
SHE:300553
China CN¥505.52 Million
New York Mortgage Trust, Inc.
NASDAQ:ADAM
USA $11.33 Billion
Zhejiang Sunflower Light Energy
SHE:300111
China CN¥153.24 Million
Shanghai Weihong Electronic Technology Co Ltd
SHE:300508
China CN¥203.38 Million
Chrysos Corporation Ltd
AU:C79
Australia AU$108.79 Million
Guangdong Chant Group Inc
SHE:002616
China CN¥7.51 Billion
Zhejiang Jasan Holding Group Co Ltd
SHG:603558
China CN¥1.57 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down Hangzhou AGS MedTech Co. Ltd. A's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 688581 total assets.

Liquidity & Leverage Metrics

Hangzhou AGS MedTech Co. Ltd. A Total Liabilities Ratios Explained

Hangzhou AGS MedTech Co. Ltd. A total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 17.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.05 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.05 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou AGS MedTech Co. Ltd. A's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou AGS MedTech Co. Ltd. A (2021–2025)

The table below shows the annual total liabilities of Hangzhou AGS MedTech Co. Ltd. A from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥160.37 Million
≈ $23.47 Million
+5.05%
2024-12-31 CN¥152.67 Million
≈ $22.34 Million
+24.29%
2023-12-31 CN¥122.83 Million
≈ $17.97 Million
+34.11%
2022-12-31 CN¥91.59 Million
≈ $13.40 Million
+29.83%
2021-12-31 CN¥70.55 Million
≈ $10.32 Million
--

About Hangzhou AGS MedTech Co. Ltd. A

SHG:688581 China Medical Devices
Market Cap
$587.60 Million
CN¥4.02 Billion CNY
Market Cap Rank
#11029 Global
#2961 in China
Share Price
CN¥49.50
Change (1 day)
-1.88%
52-Week Range
CN¥49.50 - CN¥69.80
All Time High
CN¥92.52
About

Hangzhou AGS MedTech Co., Ltd., together with its subsidiaries, engages in the research, development, production, sale, and service of endoscopic minimally invasive diagnostic and therapeutic instruments in China and internationally. The company offers hemostasis products, including hemoclips and traction clips; biopsy products, such as disposable biopsy, swinging biopsy, and grasping forceps; an… Read more